EA200802167A1 - Лекарства и применения - Google Patents
Лекарства и примененияInfo
- Publication number
- EA200802167A1 EA200802167A1 EA200802167A EA200802167A EA200802167A1 EA 200802167 A1 EA200802167 A1 EA 200802167A1 EA 200802167 A EA200802167 A EA 200802167A EA 200802167 A EA200802167 A EA 200802167A EA 200802167 A1 EA200802167 A1 EA 200802167A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- drugs
- biomolecule
- time
- present
- point
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к способам лечения некоторых клинических нарушений, таких как гипергликемия, диабет 2 типа, артрит и множественный склероз. Согласно настоящему изобретению также предложены способы идентификации и определения свойств лекарств, которые частично характеризуются различным биологическим или терапевтическим действием на биомолекулу в один момент времени и относительной нормализацией биомолекулы в другой момент времени. Указанные соединения включают 17α-этиниландрост-5-ен-3β,7β,17β-триол или андрост-5-ен-3β,4β,16α,17β-тетрол, которые можно применять в качестве стандартов для облегчения оценки и определения характеристик указанных потенциальных лекарств.
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79379206P | 2006-04-22 | 2006-04-22 | |
US84311206P | 2006-09-08 | 2006-09-08 | |
US82556906P | 2006-09-13 | 2006-09-13 | |
US82556406P | 2006-09-13 | 2006-09-13 | |
US82984806P | 2006-10-17 | 2006-10-17 | |
US86639506P | 2006-11-17 | 2006-11-17 | |
US86670006P | 2006-11-21 | 2006-11-21 | |
US86804206P | 2006-11-30 | 2006-11-30 | |
US88500307P | 2007-01-15 | 2007-01-15 | |
US88805807P | 2007-02-02 | 2007-02-02 | |
PCT/US2007/067235 WO2008039566A2 (en) | 2006-04-22 | 2007-04-23 | Drugs and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200802167A1 true EA200802167A1 (ru) | 2009-04-28 |
Family
ID=39230844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200802167A EA200802167A1 (ru) | 2006-04-22 | 2007-04-23 | Лекарства и применения |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP2012773B1 (ru) |
JP (2) | JP5130591B2 (ru) |
KR (1) | KR20080112413A (ru) |
CN (1) | CN103211821A (ru) |
AU (2) | AU2007300404B2 (ru) |
CA (1) | CA2649940C (ru) |
DK (2) | DK2486924T3 (ru) |
EA (1) | EA200802167A1 (ru) |
ES (2) | ES2389743T3 (ru) |
HU (1) | HUE042925T2 (ru) |
IL (1) | IL194751A0 (ru) |
PL (2) | PL2486924T3 (ru) |
WO (1) | WO2008039566A2 (ru) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8569275B2 (en) | 2002-08-28 | 2013-10-29 | Harbor Therapeutics, Inc. | Steroids having 7-oxgen and 17-heteroaryl substitution |
US8354396B2 (en) | 2006-11-17 | 2013-01-15 | Harbor Therapeutics, Inc. | Drug identification and treatment method |
US8217025B2 (en) | 2006-11-17 | 2012-07-10 | Harbor Therapeutics, Inc. | Drug screening and treatment methods |
US8486926B2 (en) | 2006-11-17 | 2013-07-16 | Harbor Therapeutics, Inc. | Steroid tetrol solid state forms |
CN101939009B (zh) * | 2008-02-05 | 2013-07-17 | 哈博生物科学公司 | 药学固体形式 |
PT2273994E (pt) | 2008-04-03 | 2016-03-15 | Neurmedix Inc | Formas de estado sólido de um produto farmacêutico |
DK2300489T3 (en) * | 2008-06-06 | 2016-02-15 | Neurmedix Inc | PROCESSES FOR PREPARING 17-alkynyl-7-HYDROXY STEROIDS AND RELATED COMPOUNDS |
US20130217749A1 (en) * | 2010-06-10 | 2013-08-22 | Yale University | Modulation of phosphoenolpyruvate carboxykinase-mitchondrial (pepck-m) expression |
CN103402523A (zh) * | 2010-12-17 | 2013-11-20 | 哈博生物科学公司 | 甾族化合物四醇固体形式-2 |
CN107936076B (zh) * | 2011-09-08 | 2021-10-15 | 萨奇治疗股份有限公司 | 神经活性类固醇、组合物、及其用途 |
ITMI20121472A1 (it) * | 2012-09-04 | 2014-03-05 | Ind Chimica Srl | Processo per la preparazione di 11-metilen-18-metilestr-4-en-3,17-dione, utile come intermedio per la sintesi di molecole ad attivita' farmacologica |
KR101687061B1 (ko) * | 2014-02-25 | 2016-12-16 | 순천향대학교 산학협력단 | 나이에 따른 당뇨병 진단을 위한 글루코코르티코이드 수용체의 검출제제를 포함하는 타입 2 당뇨 진단 키트 |
CN105017361A (zh) * | 2015-07-16 | 2015-11-04 | 湖北竹溪人福药业有限责任公司 | 一种去氢表雄酮的合成方法 |
CN113350359B (zh) | 2017-12-29 | 2022-08-16 | 广州市赛普特医药科技股份有限公司 | 5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用 |
CN109369760B (zh) * | 2018-12-18 | 2021-01-01 | 湖南科瑞生物制药股份有限公司 | 一种制备去氢甲基睾丸素的方法 |
CN109369761B (zh) * | 2018-12-18 | 2021-01-01 | 湖南科瑞生物制药股份有限公司 | 一种去氢甲基睾丸素的制备方法 |
CN113318114B (zh) * | 2020-02-28 | 2023-02-17 | 广州市赛普特医药科技股份有限公司 | 小分子化合物在治疗肺上皮细胞损伤和/或血管内皮细胞损伤介导的疾病中的用途 |
CN114195844B (zh) * | 2021-12-29 | 2023-03-17 | 湖北武当安泰药业有限公司 | 一种去氢表雄酮的制备方法 |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410516B1 (en) | 1986-01-09 | 2002-06-25 | President & Fellows Of Harvard College | Nuclear factors associated with transcriptional regulation |
US5071773A (en) | 1986-10-24 | 1991-12-10 | The Salk Institute For Biological Studies | Hormone receptor-related bioassays |
US4898694A (en) * | 1987-11-25 | 1990-02-06 | Schwartz Arthur G | 17-Hydroxy-steroids |
AU7978794A (en) * | 1993-10-13 | 1995-05-04 | Neurocrine Biosciences, Inc. | 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use |
US6545027B1 (en) | 1995-06-07 | 2003-04-08 | Eli Lilly And Company | Methods of modulating NF-kB transcription factor |
US5989835A (en) | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
US5753266A (en) * | 1996-12-03 | 1998-05-19 | Youssefyeh; Parvin | Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases |
US6667299B1 (en) * | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
US20030083231A1 (en) * | 1998-11-24 | 2003-05-01 | Ahlem Clarence N. | Blood cell deficiency treatment method |
AU2005211675B2 (en) * | 1999-03-23 | 2009-09-24 | Harbor Biosciences, Inc. | Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
EP1422234A3 (en) * | 1999-03-23 | 2010-12-08 | Harbor BioSciences, Inc. | Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
AU6444600A (en) * | 1999-08-06 | 2001-03-05 | Glaxo Wellcome S.A. | New protein |
EP2322182A1 (en) * | 1999-09-30 | 2011-05-18 | Harbor BioSciences, Inc. | Androstenol derivatives as androgen receptor modulator |
US6864355B1 (en) | 2000-05-02 | 2005-03-08 | Yale University | Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
US6593511B1 (en) | 2000-05-12 | 2003-07-15 | Bioseek, Inc. | Models of chronic and acute inflammatory diseases |
AU2002244247B2 (en) * | 2001-03-01 | 2007-12-13 | Harbor Biosciences, Inc. | Use of certain steroids for treatment of blood cell deficiencies |
CA2447431A1 (en) | 2001-05-11 | 2002-11-21 | Research Development Foundation | Inhibitors of receptor activator of nf-kb and uses thereof |
AU2002340119A1 (en) * | 2001-10-09 | 2003-04-22 | Immunex Corporation | Mammalian c-type lectins |
AU2003278744B2 (en) * | 2002-08-28 | 2010-07-29 | Harbor Biosciences, Inc. | Therapeutic treatment methods |
WO2004043986A1 (en) * | 2002-11-07 | 2004-05-27 | Pharmacia & Upjohn Company Llc | Processes for preparing c-7 substituted 5-androstenes |
US7884196B2 (en) | 2004-10-06 | 2011-02-08 | Oliver Lawless | Vaccine composition comprising methylated DNA and immunomodulatory motifs |
-
2007
- 2007-04-23 CN CN2013100543094A patent/CN103211821A/zh active Pending
- 2007-04-23 EP EP07863339A patent/EP2012773B1/en active Active
- 2007-04-23 PL PL12167186T patent/PL2486924T3/pl unknown
- 2007-04-23 ES ES07863339T patent/ES2389743T3/es active Active
- 2007-04-23 PL PL07863339T patent/PL2012773T3/pl unknown
- 2007-04-23 ES ES12167186T patent/ES2710288T3/es active Active
- 2007-04-23 DK DK12167186.1T patent/DK2486924T3/en active
- 2007-04-23 EA EA200802167A patent/EA200802167A1/ru unknown
- 2007-04-23 EP EP12167186.1A patent/EP2486924B1/en active Active
- 2007-04-23 JP JP2009506814A patent/JP5130591B2/ja active Active
- 2007-04-23 DK DK07863339.3T patent/DK2012773T3/da active
- 2007-04-23 CA CA2649940A patent/CA2649940C/en active Active
- 2007-04-23 AU AU2007300404A patent/AU2007300404B2/en active Active
- 2007-04-23 HU HUE12167186A patent/HUE042925T2/hu unknown
- 2007-04-23 KR KR1020087028733A patent/KR20080112413A/ko not_active Application Discontinuation
- 2007-04-23 WO PCT/US2007/067235 patent/WO2008039566A2/en active Application Filing
-
2008
- 2008-10-22 IL IL194751A patent/IL194751A0/en unknown
-
2010
- 2010-03-17 AU AU2010201023A patent/AU2010201023B2/en active Active
-
2012
- 2012-09-27 JP JP2012214102A patent/JP2012255033A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2012773A2 (en) | 2009-01-14 |
AU2007300404B2 (en) | 2009-12-17 |
EP2486924B1 (en) | 2018-12-26 |
WO2008039566A2 (en) | 2008-04-03 |
EP2012773B1 (en) | 2012-06-20 |
DK2486924T3 (en) | 2019-03-04 |
ES2710288T3 (es) | 2019-04-24 |
CA2649940C (en) | 2012-08-07 |
AU2010201023B2 (en) | 2012-02-09 |
EP2012773A4 (en) | 2010-01-13 |
DK2012773T3 (da) | 2012-09-24 |
ES2389743T3 (es) | 2012-10-31 |
WO2008039566A3 (en) | 2008-11-27 |
IL194751A0 (en) | 2009-08-03 |
KR20080112413A (ko) | 2008-12-24 |
AU2010201023A1 (en) | 2010-04-08 |
PL2486924T3 (pl) | 2019-07-31 |
AU2007300404A1 (en) | 2008-04-03 |
CA2649940A1 (en) | 2008-04-03 |
HUE042925T2 (hu) | 2019-07-29 |
EP2486924A3 (en) | 2013-01-09 |
PL2012773T3 (pl) | 2012-12-31 |
CN103211821A (zh) | 2013-07-24 |
JP2009534427A (ja) | 2009-09-24 |
JP2012255033A (ja) | 2012-12-27 |
EP2486924A2 (en) | 2012-08-15 |
JP5130591B2 (ja) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200802167A1 (ru) | Лекарства и применения | |
LTPA2017009I1 (lt) | Brutono tirozinkinazės inhibitoriai | |
EP3552607A3 (en) | Imidazopyrazine syk inhibitors | |
MX2008009886A (es) | Anticuerpos que enlazan par-2. | |
MX2009012950A (es) | ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS. | |
UA96308C2 (ru) | Антагонисты рецептора глюкагона, композиция, которая содержит такие соединения, и их применение | |
EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
WO2010009342A3 (en) | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors | |
MX2009012625A (es) | Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21. | |
WO2009038689A3 (en) | Compositions and methods for diagnosis and treatment of type 2 diabetes | |
MY145349A (en) | Benzofuro- and benzothienopyrimidine modulators of the histamine h4 receptor | |
CL2008002506A1 (es) | Compuestos derivados de bencimidazol sustituido, procedimiento de preparacion, composicion farmaceutica, util en el tratamiento de enfermedades moduladas con antagonistas del receptor fxr, en particular para el tratamiento de los niveles incrementados de lipidos y/o colesterol, enfermedad aterosclerotica, diabetes, cancer, parkinson, alzheimer. | |
EA201990619A1 (ru) | Fgf21 мутанты и их применение | |
WO2008018642A3 (en) | Genes and polypeptides relating to breast cancers | |
WO2007109236A3 (en) | Microrna fingerprints during human megakaryocytopoiesis | |
WO2006105516A3 (en) | Compositions and methods for diagnosing and treating neuropsychiatric disorders | |
MX350010B (es) | Inhibidores syk de imidazopiridinas. | |
NO20054769L (no) | Substituerte fenylalkansyrer | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
EP2985281A3 (en) | Isoindoline compounds for use in the treatment of cancer | |
WO2008030273A3 (en) | Compositions and methods for diagnosis and treatment of type 2 diabetes | |
EA201290894A1 (ru) | Азетидиновые производные пиперидин-4-ила как ингибиторы jak1 | |
EA201001883A1 (ru) | Мутанты fgf21 и их применение | |
EA200970302A1 (ru) | Тиофенпиразолопиримидиновые соединения |